Table 2 Estimated effects of COVID period on the use of respiratory interventions and mortality in patients with acute respiratory distress comparing the COVID with the pre-COVID period
From: The COVID-19 pandemic: the effect on airway Management in non-COVID emergency patients
Outcomes | Pre-COVID (n = 360) | COVID (n = 333) | Adjusted OR (95%CI) | ||
|---|---|---|---|---|---|
n | % (95%CI) | n | % (95%CI) | ||
Respiratory interventions | |||||
Inverse PS score weighted | |||||
Initial NIVHFNC use | 15 | 4.2 (2.3, 6.8) | 7 | 2.1 (0.8, 4.3) | 0.40 (0.16, 1.00) |
NIVHFNC use | 36 | 10.0 (7.1, 13.6) | 21 | 6.3 (3.9, 9.5) | 0.52 (0.29, 0.92) |
a Intubation | 55 | 21.7 (16.8, 27.3) | 49 | 19.5 (14.8, 24.9) | 0.94 (0.46, 1.32) |
Pneumonia | 34 | 32.1 (23.3, 41.8) | 29 | 26.4 (18.4, 35.6) | 0.76 (0.42, 1.37) |
COPD/Asthma | 8 | 8.6 (3.8, 16.2) | 7 | 10.0 (4.1, 19.5) | 1.18 (0.41, 3.42) |
Pulmonary edema | 10 | 14.1 (7.0, 24.4) | 18 | 23.4 (14.5, 34.4) | 1.86 (0.79, 4.36) |
Mortality | |||||
Multivariable logistic regression | |||||
Non-survivor within 30 days | 89 | 24.7 (20.4, 29.5) | 43 | 12.9 (9.5, 17.0) | 0.50 (0.33, 0.76) |
Pneumonia | 75 | 37.4 (30.8, 44.4) | 36 | 19.7 (14.1, 26.3) | 0.48 (0.29, 0.77) |
COPD/Asthma | 11 | 11.8 (6.2, 19.6) | 2 | 2.6 (0.3, 9.2) | -b |
Pulmonary edema | 3 | 4.0 (0.8, 11.2) | 5 | 5.8 (1.9, 13.0) | -b |
In-hospital mortality | 72 | 20.0 (16.0, 24.5) | 40 | 12.0 (8.7, 16.0) | 0.62 (0.40, 0.95) |